Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program

CompletedOBSERVATIONAL
Enrollment

64

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Multiple Sclerosis
Interventions
DRUG

fingolimod

Trial Locations (58)

10029

Mount Sinai School of Medicine, New York

11794

SUNY - Stony Brook University, Stony Brook

11803

Island Neurological Associates, Plainview

19104

University of Pennsylvania Health System, Philadelphia

19107

Thomas Jerfferson University Hospital, Philadelphia

20007

Georgetown University/Lombardi Cancer Center, Washington D.C.

21201

University of Maryland, Baltimore

21287

Johns Hopkins MS Center, Baltimore

22903

University of Virginia Health System, Charlottesville

32209

University of Florida, Jacksonville

32308

AMO Corporation, Tallahassee

32960

MS Center of Vero Beach, Vero Beach

33021

Sunrise Clinical Research, Inc., Hollywood

33060

Neurological Associates, Pompano Beach

33136

University of Miami, Miami

33351

Neurology Clinical Research, Inc., Sunrise

35058

North Central Neurology Associates, PC, Cullman

37204

Vanderbilt University, Nashville

43614

University of Toledo Health Science Campus, Toledo

49525

Spectrum Health Medical Group, Neurology, Grand Rapids

50314

Mercy Ruan Neurology Clinic Res Ct., Des Moines

53215

St. Luke's Medical Center, Milwaukee

53715

Dean Foundation, Madison

53792

University of Wisconsin Madison, Madison

60422

South Suburban Neurology, Flossmoor

60463

Neurologic Associates, LTD, Palos Heights

63131

The MS Center for Innovation in Care, St Louis

64111

Saint Luke's Hospital, Kansas City

66160

University of Kansas Medical Center, Kansas City

66214

Mid America Neuroscience Institute, Lenexa

73120

MS Center of Oklahoma, Oklahoma City

74137

Neurological Associates of Tulsa, Inc, Tulsa

77030

University of Texas Medical School, Houston

78231

Integra Clinical Research, San Antonio

87131

University of New Mexico Health Science Center, Albuquerque

91105

Neuro-Therapeutics, Inc., Pasadena

94117

University of California San Francisco, San Francisco

94705

The Research & Education Inst. of Alta Bates Summit Med. Grp, Berkeley

98122

Swedish Neuroscience Institute, Seattle

06510

Yale Multiple Sclerosis Center, New Haven

02135

Caritas St. Elizabeth's Hospital, Boston

01104

Springfield Neurology Associates, LLC, Springfield

V5G 2X6

Novartis Investigative Site, Burnaby

V6T 2B5

Novartis Investigative Site, Vancouver

V8R 1J8

Novartis Investigative Site, Victoria

B3H 4K4

Novartis Investigative Site, Halifax

K7L 2V7

Novartis Investigative Site, Kingston

N6A 5A5

Novartis Investigative Site, London

K2G 6E2

Novartis Investigative Site, Nepean

K1H 8L6

Novartis Investigative Site, Ottawa

M5B 1W8

Novartis Investigative Site, Toronto

J4V 2J2

Novartis Investigative Site, Greenfield Park

H1T 2M4

Novartis Investigative Site, Montreal

H2L 4M1

Novartis Investigative Site, Montreal

H3A 2B4

Novartis Investigative Site, Montreal

G1J 1Z4

Novartis Investigative Site, Québec

J1H 5N4

Novartis Investigative Site, Sherbrooke

S4T 1A5

Novartis Investigative Site, Regina

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY